# SC Laboratories

SC Laboratories is an other based in Santa Cruz, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Santa Cruz, United States
- **Region:** North America
- **Address:** Santa Cruz, CA, United States
- **Founded:** 2010
- **Assets under management:** Undisclosed
- **Website:** sclabs.com

## Regulatory record

- **Reports private funds:** No

## About

Cannabis and hemp testing and analysis you can use to build your reputation and grow your business.

## Sectors

- Cannabis
- AgriTech & FoodTech
- Healthcare Services

## Offices

- Arizona
- Oregon
- Colorado
- Michigan

## People

- Jeff Gray — Chief Executive Officer
- Alec Dixon — Executive VP, Client Relations
- Ryan DeCurtis — Senior VP, Technology

## Questions

### Who runs investment and strategic decisions at SC Laboratories?

Jeff Gray serves as CEO, Alec Dixon is Executive VP of Client Relations, and Ryan DeCurtis is Senior VP of Technology. The three co-founders — Gray, Dixon, and Josh Wurzer (Chief Operating Officer) — have shaped the firm's direction since 2010. The company also maintains a board of advisors including Shaun Kelley, Amy McDonald, Mike Branvold, and Hirsh Jain.

### How does SC Laboratories source business outside its home state of California?

SC Laboratories operates cannabis testing facilities in Arizona, Oregon, Colorado, and Michigan, and runs a national hemp testing panel registered in Idaho, Illinois, New Mexico, New York, and Texas. Multi-state cannabis operators contract with SC Labs across these jurisdictions, while hemp clients can ship samples to the national panel regardless of their home state. The firm's R&D Center of Excellence in Santa Cruz supports all locations.

### What testing services does SC Laboratories provide?

The lab performs potency analysis, terpene profiling, pesticide screening, heavy metals testing, residual solvents analysis, and microbiological contamination detection. Its chemometric terpene reporting categorizes strains by chemical profile rather than the traditional indica/sativa/hybrid taxonomy, a shift the firm has advocated publicly since at least 2023. On the hemp side, it also tests for Delta-8 THC adulterants and synthesis byproducts.

### What is SC Laboratories' known posture on co-investments or partnerships with external entities?

SC Laboratories has not disclosed any co-investment vehicles, partnership funds, or external investment positions. It presents itself as an independent operating company serving growers, extractors, product makers, and retailers. Its board of advisors includes individuals from outside the firm, but the nature of their engagement has not been characterized as investment-related.

### How does SC Laboratories compare to other multi-state cannabis testing labs?

SC Laboratories claims to be the largest multi-state cannabis testing lab by facility count and geographic reach, with active cannabis labs in five states and registered hemp testing in five additional states. Its chemometric terpene reporting system and a stated data set of over 740,000 tests differentiate it from labs that report only potency and safety metrics. The firm's public advocacy for retiring the indica/sativa classification and for federal hemp testing harmonization adds an industry-standard-setting dimension not commonly seen among regional competitors.

## Related profiles

- [SBI Shinsei Corporate Investment](https://altss.com/profile/sbi-shinsei-corporate-investment)
- [SCA Health](https://altss.com/profile/sca-health)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sc-laboratories

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology